Literature DB >> 24410

Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic.

M A Foglesong, J W Lamb, J V Dietz.   

Abstract

Cefaclor solutions in pH 2.5 and 4.5 buffers contained at least 90% of their initial activity after 72 h at 4 degrees C. Samples in pH 6.0, 7.0, and 8.0 buffers contained 70, 46, and 34%, respectively, of their initial activity after 72 h at 4 degrees C. After 72 h at 25 degrees C, samples prepared with pH 2.5, 4.5, 6.0, 7.0, and 8.0 buffers contained 95, 69, 16, 5, and 3%, respectively, of their initial activity. After 72 h at 37 degrees C, cefaclor solutions in pH 2.5 buffer contained 80% of the initial activity, whereas samples prepared in pH 4.5, 6.0, 7.0, and 8.0 buffers contained less than 20%. Laboratory-prepared plasma and serum samples showed an 8% loss in activity when incubated for 6 h at 4 degrees C, a 51% loss when incubated for 6 h at 25 degrees C, and a 48% loss when incubated for 2 h at 37 degrees C. Clinical samples demonstrated a similar stability pattern. Degradation rates for cefaclor in commercially prepared serum increased from 4- to 10-fold in comparison to rates obtained when samples were made in human serum freshly prepared in our laboratory. Consequently, serum standards should be made in freshly prepared human serum.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 24410      PMCID: PMC352183          DOI: 10.1128/AAC.13.1.49

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

1.  Metabolism of (14C) cefaclor, a cephalosporin antibiotic, in three species of laboratory animals.

Authors:  H R Sullivan; S L Due; D L Kau; J F Quay; W Miller
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

2.  Automated system for analytical microbiology. II. Construction of system and evaluation of antibiotics and vitamins.

Authors:  N R Kuzel; F W Kavanagh
Journal:  J Pharm Sci       Date:  1971-05       Impact factor: 3.534

  2 in total
  15 in total

1.  Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats.

Authors:  A De La Peña; T Dalla Costa; J D Talton; E Rehak; J Gross; U Thyroff-Friesinger; A I Webb; M Müller; H Derendorf
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.

Authors:  R N Jones; A L Barry
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

4.  [Assay of cefaclor in serum and urine (including stability test) using high pressure liquid chromatography (author's transl)].

Authors:  E Harhausen; C Simon
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.

Authors:  J H Jorgensen; J S Redding; L A Maher
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

6.  In vitro activities of LY163892, cefaclor, and cefuroxime.

Authors:  C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

7.  Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic technique.

Authors:  J C Rotschafer; K B Crossley; T S Lesar; D Zaske; K Miller
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

8.  Pharmacokinetics of cefaclor in patients with end stage renal disease and during hemodialysis.

Authors:  S J Berman; W H Boughton; J G Sugihara; E G Wong; M M Sato; A W Siemsen
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

9.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

10.  [In vitro activity of cefaclor (author's transl)].

Authors:  H Knothe
Journal:  Infection       Date:  1979       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.